• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesView this articleSubmit a manuscriptReceive email alertsContact usBMJ
Ann Rheum Dis. Feb 1992; 51(2): 249–252.
PMCID: PMC1005668

White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration induced white finger syndrome.


Systemic sclerosis (SSc) and vibration induced white finger syndrome (VWF) are common causes of secondary Raynaud's phenomenon. Previous studies have suggested an increase in inflammation in patients with SSc. Vibration induced white finger syndrome occurs in workers exposed to vibration and is now a prescribed disease. In VWF, although it is recognised that vibration can cause direct damage to blood vessels, it does not explain why only some workers are affected. It is possible that an inflammatory process develops in these patients in the same way as is seen in SSc. Leukotriene B4, produced mainly by polymorphonuclear cells, is a potent mediator of inflammation. The plasma thiol concentration shows the degree of oxidation of plasma and a decreased concentration indicates the increased production of free radicals which are capable of oxidative damage. In this work, the white blood cell (WBC) production of leukotriene B4 and plasma thiol concentrations were measured in patients with SSc and VWF. Fifty nine patients were studied: 34 had SSc and 25 had VWF. The results were compared with 25 matched normal controls and are expressed as the median and range. After stimulation of the polymorphonuclear cells with calcium ionophore A23187 (1 microgram/ml), patients with SSc and VWF were found to have significantly increased leukotriene B4 production (23.5 (14.4-44.0) and 26 (14.4-39.4) ng/10(6) cells, respectively) compared with normal controls (17.2 (6.0-38.0) ng/10(6) cells). The plasma thiol concentration was shown to be significantly lower in patients with SSc and VWF (445 (375-475) and 450 (417-510) mumol/l, respectively) compared with normal controls (480 (418-555) mumol/l). Our results show increased leukotriene B4 production and increased free radical activity in patients with SSc and VWF. Although previous indirect evidence has suggested increased WBC activity in patients with SSc, this is reported directly here for the first time. In addition, the possibility of an inflammatory process occurring in patients with VWF, as shown here, has not previously been studied. This may be a further mechanism to explain the poor circulation in the fingers of these patients.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (673K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Akesson A, Wollheim FA. Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma. Br J Rheumatol. 1989 Aug;28(4):281–286. [PubMed]
  • Jayson MI. The micro-circulation in systemic sclerosis. Clin Exp Rheumatol. 1984 Jan-Mar;2(1):85–91. [PubMed]
  • Salmon JA, Simmons PM, Palmer RM. A radioimmunoassay for leukotriene B4. Prostaglandins. 1982 Aug;24(2):225–235. [PubMed]
  • Del Maestro RF. An approach to free radicals in medicine and biology. Acta Physiol Scand Suppl. 1980;492:153–168. [PubMed]
  • ELLMAN GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959 May;82(1):70–77. [PubMed]
  • Haataja M, Kalliomäki JL. Serum sulfhydryl groups in rheumatoid arthritis. Z Rheumatol. 1977 Mar-Apr;36(3-4):73–76. [PubMed]
  • Taylor W. Vibration white finger: a newly prescribed disease. Br Med J (Clin Res Ed) 1985 Oct 5;291(6500):921–922. [PMC free article] [PubMed]
  • Kahaleh MB, Osborn I, LeRoy EC. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon. Ann Intern Med. 1981 Apr;94(4 Pt 1):482–484. [PubMed]
  • Belch JJ, Zoma AA, Richards IM, McLaughlin K, Forbes CD, Sturrock RD. Vascular damage and factor-VIII-related antigen in the rheumatic diseases. Rheumatol Int. 1987;7(3):107–111. [PubMed]
  • Leroy EC, Smith EA, Kahaleh MB, Trojanowska M, Silver RM. A strategy for determining the pathogenesis of systemic sclerosis. Is transforming growth factor beta the answer? Arthritis Rheum. 1989 Jul;32(7):817–825. [PubMed]
  • Spisani S, Dovigo L, Colamussi V. Leukocyte migration and phagocytosis in progressive systemic sclerosis. Scand J Rheumatol. 1981;10(4):299–300. [PubMed]
  • Fisher TC, Belch JJ, Barbenel JC, Fisher AC. Human whole-blood granulocyte aggregation in vitro. Clin Sci (Lond) 1989 Feb;76(2):183–187. [PubMed]
  • Maslen CL, Hall ND, Woolf AD, Maddison PJ. Enhanced oxidative metabolism of neutrophils from patients with systemic sclerosis. Br J Rheumatol. 1987 Apr;26(2):113–117. [PubMed]
  • Banford JC, Brown DH, Hazelton RA, McNeil CJ, Smith WE, Sturrock RD. Altered thiol status in patients with rheumatoid arthritis. Rheumatol Int. 1982;2(3):107–111. [PubMed]
  • Pullar T, Zoma A, Capell HA, Khan MF, Brown DH, Smith WE. Alteration of thiol and superoxide dismutase status in rheumatoid arthritis treated with sulphasalazine. Br J Rheumatol. 1987 Jun;26(3):202–206. [PubMed]
  • Chopra M, Belch JJ, Smith WE. A comparison of the free radical scavenging activity of leukotrienes and prostaglandins. Free Radic Res Commun. 1988;5(2):95–99. [PubMed]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...